Cargando…

LSD1-targeted therapy—a multi-purpose key to unlock immunotherapy in small cell lung cancer

Detalles Bibliográficos
Autores principales:	Sattler, Martin, Salgia, Ravi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326781/ https://www.ncbi.nlm.nih.gov/pubmed/37425423 http://dx.doi.org/10.21037/tlcr-23-40

Ejemplares similares

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)
por: Salgia, Ravi, et al.
Publicado: (2021)

Many Keys Unlock the Doors for Virus Entry
por: Gallagher, Tom
Publicado: (2022)

Antitumor activity of LSD1 inhibitors in lung cancer
por: Mohammad, Helai P., et al.
Publicado: (2016)

Targeting LSD2 in breast cancer
por: Huang, Yi, et al.
Publicado: (2018)

Powering up antifungal treatment: using small molecules to unlock the potential of existing therapies
por: Shapiro, Rebecca S., et al.
Publicado: (2023)

The KEY for chemo-immunotherapy combination: taking NOTEs from squamous cell lung cancer
por: Reale, Maria Lucia, et al.
Publicado: (2020)

Immunotherapy as a targeted therapy in non-small cell lung cancer
por: Rocco, Danilo, et al.
Publicado: (2019)

Targeting Histone Demethylase LSD1/KDM1a in Neurodegenerative Diseases
por: Ambrosio, Susanna, et al.
Publicado: (2018)

Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?
por: Villaflor, Victoria M., et al.
Publicado: (2013)

Unlocking the bovine genome
por: Tellam, Ross L, et al.
Publicado: (2009)

Targeting oral cancer epigenome via LSD1
por: Bais, Manish V.
Publicado: (2017)

The tango of immunotherapy and targeted therapy in metastatic renal cell carcinoma
por: Rathi, Nityam, et al.
Publicado: (2019)

Stamp out lung cancer
por: Salgia, Ravi
Publicado: (2008)

Unlocking the potential of non-coding RNAs in cancer research and therapy
por: Uppaluri, Kalyan Ram, et al.
Publicado: (2023)

CEACAM1 as a multi-purpose target for cancer immunotherapy
por: Dankner, Matthew, et al.
Publicado: (2017)

Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases
por: Rutkowski, Piotr, et al.
Publicado: (2023)

Neoadjuvant immunotherapy with resectable non-small cell lung cancer: recent advances and future challenges
por: Ren, Sijia, et al.
Publicado: (2020)

Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail
por: Cali Daylan, Ayse Ece, et al.
Publicado: (2023)

Taking it up a notch: a promising immunotherapy against small cell lung cancer
por: Apaydin, Alanisse A., et al.
Publicado: (2023)

Targeting LSD1 in tumor immunotherapy: rationale, challenges and potential
por: Bao, Lei, et al.
Publicado: (2023)

How to lead a values-based professional services firm: 3 keys to unlock purpose and profit
por: Scales, Don, et al.
Publicado: (2020)

Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)
por: Yellala, Amulya, et al.
Publicado: (2020)

A Special Key for Unlocking the Door to Targeted Therapies of Breast Cancer
por: Lindemann, Kristina, et al.
Publicado: (2008)

Targeted Protein Degradation: Unlocking the Therapeutic Proteome
por: EBioMedicine
Publicado: (2018)

Unlocking the secrets to human NTCP structure
por: Qi, Xiangbing, et al.
Publicado: (2022)

Single-cell insights into the dynamic tumor microenvironment changes during immunotherapy of non-small cell lung cancer
por: Prazanowska, Karolina Hanna, et al.
Publicado: (2023)

Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma
por: Salgia, Ravi
Publicado: (2016)

New potential targeted strategies in small cell lung cancer
por: de Toro, María, et al.
Publicado: (2023)

Implications of the success of EGFR-targeted therapy in advanced non–small cell lung cancer for its application to the adjuvant setting
por: Takeda, Masayuki
Publicado: (2020)

Unlocking the potential of fungi: the QuantFung project
por: Büttel, Zsófia, et al.
Publicado: (2015)

Telling tales: unlocking the potential of AAC technologies
por: Waller, Annalu
Publicado: (2018)

Back to the Future: Multiparent Populations Provide the Key to Unlocking the Genetic Basis of Complex Traits
por: de Koning, Dirk-Jan, et al.
Publicado: (2017)

CD4 T cells: the complicated key to unlocking the immune environment of classical Hodgkin lymphoma
por: Gandhi, Maher K., et al.
Publicado: (2022)

Characterization of the tumor microenvironment by single-cell RNA sequencing in non-small cell lung cancer treated with neo-adjuvant immunotherapy
por: Nagl, Laurenz, et al.
Publicado: (2023)

EGFR-Targeted Therapeutics: Focus on SCCHN and NSCLC
por: Sattler, Martin, et al.
Publicado: (2008)

Immunotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: Clinical Challenges and Future Directions
por: Pathak, Ranjan, et al.
Publicado: (2021)

Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?
por: Hida, Toyoaki, et al.
Publicado: (2020)

CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy
por: Jain, Swati, et al.
Publicado: (2023)

Rapid progression of disease from immunotherapy following targeted therapy: insights into treatment management and sequence
por: Pharaon, Rebecca, et al.
Publicado: (2020)

Xtreme Everest 2: unlocking the secrets of the Sherpa phenotype?
por: Martin, Daniel S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lb3cc0l850p5gep1td77rk4l53